Bitcoin vs Real Estate: A Billionaire’s Bold Take
A prominent billionaire argues Bitcoin outperforms real estate as an investment. We analyze both assets to help you decide.
SpaceX’s Orbital Data Centers: Execution Risk Ahead
SpaceX's ambitious orbital data center plans face significant hurdles. Here's what investors need to know about the risks and opportunities.
Vanguard VB vs iShares ISCB: Small-Cap ETF Showdown
Compare Vanguard VB and iShares ISCB small-cap ETFs. Analyze diversification, sector exposure, and risk to find your ideal match.
Three Magnificent Seven Stocks Worth Buying Today
Nvidia, Microsoft, and Meta emerge as top investment opportunities among the Magnificent Seven. Learn why these tech giants deserve a place in your portfolio.
OpenAI Academy Launches Courses for AI-Ready Workers
OpenAI introduces three Academy courses designed to help professionals build practical AI skills and implement intelligent agents in their daily work.
OpenAI Launches $150M Partner Network for Enterprise AI
OpenAI unveils Partner Network with $150M investment to accelerate enterprise AI adoption and transformation globally.
OpenAI’s Deployment Simulation Predicts AI Model Behavior Before Launch
OpenAI introduces Deployment Simulation to predict AI model behavior using real conversation data, enhancing safety protocols and evaluation accuracy before deployment.
LifeSciBench: New AI Benchmark for Life Sciences Research
LifeSciBench offers expert-reviewed evaluation of AI systems in real-world life science research tasks, setting new standards for biotech innovation.
AI Chemist Breakthrough Accelerates Drug Development
OpenAI and Molecule.one deploy autonomous AI to optimize complex medicinal chemistry reactions, marking a major advancement in pharmaceutical research.
AI Breakthrough Diagnoses Rare Genetic Diseases in Children
OpenAI's advanced reasoning model helps physicians solve 18 previously unsolved rare genetic disease cases in children, transforming pediatric diagnostics.